Tag Archives: CLBS

Top Medical Stocks To Watch For 2019

The legal marijuana landscape is changing at a rapid pace in North America. Back in 1995, Canada, Mexico, and all U.S. states had completely banned the use of medical and recreational pot. Some 23 years later, Mexico has legalized medical cannabis, 30 U.S. states have passed broad-based medical marijuana laws (including nine that also allow adult-use consumption), and Canada has set a date of Oct. 17, 2018 for when recreational pot will be officially legal. To say that times are changing would be an understatement.

Most are rightly focused on Canada’s adult-use legalization, which is the first for any developed country around the globe. With pot being given the green light there, an estimated $5 billion in annual sales could find its way into legal Canadian marijuana channels. This is why Canadian cannabis stock valuations have soared since the beginning of 2016.

Image source: Getty Images.

Top Medical Stocks To Watch For 2019: Southwestern Energy Company(SWN)

Advisors’ Opinion:

  • [By Max Byerly]

    Prudential Financial Inc. grew its stake in shares of Southwestern Energy (NYSE:SWN) by 7.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,113,234 shares of the energy company’s stock after buying an additional 143,547 shares during the period. Prudential Financial Inc. owned 0.36% of Southwestern Energy worth $9,150,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Southwestern Energy (NYSE:SWN) – Research analysts at Mitsubishi UFJ Financial Group lifted their Q1 2019 earnings per share estimates for Southwestern Energy in a report released on Monday, March 4th. Mitsubishi UFJ Financial Group analyst M. Mcallister now expects that the energy company will post earnings of $0.41 per share for the quarter, up from their previous forecast of $0.37. Mitsubishi UFJ Financial Group has a “Neutral” rating and a $5.00 price target on the stock. Mitsubishi UFJ Financial Group also issued estimates for Southwestern Energy’s Q2 2019 earnings at $0.16 EPS, Q3 2019 earnings at $0.22 EPS, Q4 2019 earnings at $0.15 EPS, FY2019 earnings at $0.94 EPS, Q1 2020 earnings at $0.36 EPS, Q2 2020 earnings at $0.19 EPS, Q3 2020 earnings at $0.25 EPS, Q4 2020 earnings at $0.18 EPS and FY2020 earnings at $0.99 EPS.

  • [By Ethan Ryder]

    BlueMountain Capital Management LLC boosted its holdings in Southwestern Energy (NYSE:SWN) by 290.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 167,089 shares of the energy company’s stock after purchasing an additional 124,248 shares during the period. BlueMountain Capital Management LLC’s holdings in Southwestern Energy were worth $886,000 at the end of the most recent reporting period.

  • [By WWW.GURUFOCUS.COM]

    For the details of DFT Energy LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=DFT+Energy+LP

    These are the top 5 holdings of DFT Energy LPWhiting Petroleum Corp (WLL) – 400,000 shares, 18.19% of the total portfolio. Shares added by 2.56%Hess Corp (HES) – 170,000 shares, 11.57% of the total portfolio. Shares added by 30.77%Noble Energy Inc (NBL) – 200,000 shares, 8.15% of the total portfolio. Southwestern Energy Co (SWN) – 1,360,000 shares, 7.92% of the total portfolio. Shares added by 4.62%Anadarko Petroleum Corp (APC)

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss in the S&P 500 ahead of the close was Southwestern Energy Co. (NYSE: SWN) which fell about 10% to $5.17. The stock’s 52-week range is $3.42 to $6.72. Volume was about 40.5 million compared to the daily average volume of 17.4 million.

Top Medical Stocks To Watch For 2019: Israel Chemicals Shs(ICL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Israel Chemicals (ICL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Israel Chemicals (NYSE: ICL) and Evogene (NASDAQ:EVGN) are both basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

  • [By Stephan Byrd]

    Schroder Investment Management Group boosted its position in shares of Israel Chemicals Ltd (NYSE:ICL) by 43.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 655,043 shares of the basic materials company’s stock after acquiring an additional 199,511 shares during the period. Schroder Investment Management Group owned approximately 0.05% of Israel Chemicals worth $10,939,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Israel Chemicals (NYSE:ICL) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Kingstone Companies (NASDAQ:KINS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

Top Medical Stocks To Watch For 2019: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    News coverage about Caladrius Biosciences (NASDAQ:CLBS) has trended somewhat positive on Friday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Caladrius Biosciences earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 45.4362129030389 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Watch For 2019: FIRST REPUBLIC BANK(FRC)

Advisors’ Opinion:

  • [By Max Byerly]

    MUFG Americas Holdings Corp lessened its position in shares of First Republic Bank (NYSE:FRC) by 19.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,956 shares of the bank’s stock after selling 3,360 shares during the period. MUFG Americas Holdings Corp’s holdings in First Republic Bank were worth $1,292,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Ethan Ryder]

    Commerce Bank lessened its stake in shares of First Republic Bank (NYSE:FRC) by 76.8% in the 1st quarter, HoldingsChannel reports. The fund owned 56,614 shares of the bank’s stock after selling 187,752 shares during the period. Commerce Bank’s holdings in First Republic Bank were worth $5,243,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Mackay Shields LLC bought a new stake in First Republic Bank (NYSE:FRC) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 12,402 shares of the bank’s stock, valued at approximately $1,149,000.

  • [By Logan Wallace]

    Barclays (NYSE:BCS) and First Republic Bank (NYSE:FRC) are both large-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations.

  • [By Joseph Griffin]

    ILLEGAL ACTIVITY NOTICE: “PNC Financial Services Group Inc. Has $2.34 Million Stake in First Republic Bank (FRC)” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at www.tickerreport.com/banking-finance/4208270/pnc-financial-services-group-inc-has-2-34-million-stake-in-first-republic-bank-frc.html.

Top Medical Stocks To Watch For 2019: Amedisys Inc(AMED)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Amedisys (AMED)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Amedisys (AMED)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribing]

    Amedisys (NASDAQ:AMED) Q4 2018 Earnings Conference CallFeb. 28, 2019 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Amedisys (AMED)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Insurance Stocks To Own Right Now

RenaissanceRe Holdings (RNR) is a global provider of reinsurance, as well as various types of insurance and related services. The company was founded in 1993 and is headquartered in Bermuda, notes Jack Adamo, editor of Insiders Plus.

The company operates through three segments: Catastrophe Reinsurance, Specialty Reinsurance, and Lloyd’s segments (Lloyd’s of London).

Within these segments are covered property claims, automobile liability, catastrophe exposed workers’ compensation, cyber liability, directors and officers liability, environmental liability, medical malpractice, and professional indemnity among many others types.

RenaissanceRe Holdings Ltd. 5.375% Series E Preference Shares (RNR-E) are selling at a 6.7% discount to their redemption price, giving them a current yield of 5.74% and an annualized total return of 9.94% if they are redeemed in June of 2018, when they are eligible to be redeemed by the company.

Hot Insurance Stocks To Own Right Now: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Shane Hupp]

    News coverage about Caladrius Biosciences (NASDAQ:CLBS) has trended somewhat positive on Friday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Caladrius Biosciences earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 45.4362129030389 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Insurance Stocks To Own Right Now: Ideal Power Inc.(IPWR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the news headlines that may have effected Accern Sentiment’s rankings:

    Get Ideal Power alerts:

    Ideal Power (IPWR) Expected to Announce Quarterly Sales of $390,000.00 (americanbankingnews.com) -$0.15 EPS Expected for Ideal Power (IPWR) This Quarter (americanbankingnews.com) Ideal Power Receives 1.1 Megawatt Purchase Order for its SunDial™ Plus Inverters (investingnews.com) Ideal Power Receives 1.1 Megawatt Purchase Order for its SunDial™ Plus Inverters from NEXTracker for One of the Largest Solar-and-Storage Installations in Iowa (finance.yahoo.com)

    A number of equities analysts have commented on the stock. Zacks Investment Research raised shares of Ideal Power from a “hold” rating to a “buy” rating and set a $1.50 price target for the company in a research note on Wednesday, January 10th. HC Wainwright reissued a “buy” rating and issued a $4.00 price target on shares of Ideal Power in a research note on Wednesday, March 7th. Roth Capital reissued a “hold” rating and issued a $1.00 price target on shares of Ideal Power in a research note on Wednesday, March 7th. Finally, B. Riley cut shares of Ideal Power from a “buy” rating to a “neutral” rating and cut their price target for the stock from $5.00 to $2.50 in a research note on Wednesday, March 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the stock. Ideal Power currently has a consensus rating of “Hold” and a consensus price target of $3.00.

  • [By Logan Wallace]

    Ideal Power (NASDAQ: IPWR) and Hollysys Automation Technologies (NASDAQ:HOLI) are both small-cap industrial products companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings.

  • [By Max Byerly]

    News articles about Ideal Power (NASDAQ:IPWR) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Ideal Power earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave press coverage about the industrial products company an impact score of 47.3748047378114 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Ideal Power (IPWR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Insurance Stocks To Own Right Now: PAREXEL International Corporation(PRXL)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about PAREXEL International (NASDAQ:PRXL) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. PAREXEL International earned a news impact score of 0.18 on Accern’s scale. Accern also gave press coverage about the medical research company an impact score of 49.4978250148766 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Performing Stocks To Invest In Right Now

&l;a href=&q;http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=t&a;amp;tab=searchtabquotesdark&q; target=&q;_blank&q;&g;AT&a;amp;T&a;rsquo;s&l;/a&g; stock has been underperforming somewhat over the last year, declining from as&a;nbsp;high as $41 in 2017 to around $32 currently on account of a mixed performance in the wireless business, headwinds in the U.S. pay-TV market and regulatory uncertainty surrounding its planned acquisition of media behemoth Time Warner. In this note, we take a look at some of the factors impacting AT&a;amp;T and what&a;rsquo;s driving our price estimate for the company.

We have created an &l;strong&g;&l;a href=&q;http://dashboards.trefis.com/no-login-required/CdmAAGny?fromforbesandarticle=why-atts-stock-has-been-underperforming&q; target=&q;_blank&q;&g;interactive dashboard analysis&l;/a&g; &l;/strong&g;which outlines our expectations for AT&a;amp;T over 2018. You can modify key drivers to arrive at your own forecasts for the company&a;rsquo;s revenues and EPS. Here is more on how&a;nbsp;&l;a href=&q;https://www.trefis.com/?fromforbesandarticle=why-att-stock-underperforming&q; target=&q;_blank&q;&g;&l;strong&g;i&l;/strong&g;&l;b&g;nstitutional investors and private equity firms &l;/b&g;&l;/a&g;&l;span&g;leverage Trefis technology.&l;/span&g;

Top 10 Performing Stocks To Invest In Right Now: FormFactor, Inc.(FORM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Victory Capital Management Inc. increased its stake in shares of FormFactor, Inc. (NASDAQ:FORM) by 12.1% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 1,884,057 shares of the semiconductor company’s stock after buying an additional 203,451 shares during the period. Victory Capital Management Inc.’s holdings in FormFactor were worth $25,058,000 at the end of the most recent reporting period.

  • [By Brian Feroldi]

    FormFactor (NASDAQ:FORM), which manufactures testing equipment for semiconductor components, reported its second-quarter results on Wednesday, and as expected, the company posted year-over-year declines in revenue and profits. However, the declines were not as bad as management had projected. Margins also held up well during the trying period. Traders bid up the stock in response to the better-than-expected quarterly results and on the hope that the bottom is in the rearview mirror.

  • [By Max Byerly]

    Shares of FormFactor, Inc. (NASDAQ:FORM) have been assigned a consensus rating of “Buy” from the nine research firms that are presently covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $17.90.

  • [By Stephan Byrd]

    FormFactor (NASDAQ:FORM) was downgraded by ValuEngine from a “hold” rating to a “sell” rating in a report released on Monday.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on FormFactor (FORM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    News coverage about Caladrius Biosciences (NASDAQ:CLBS) has trended somewhat positive on Friday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Caladrius Biosciences earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 45.4362129030389 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: Liberty TripAdvisor Holdings, Inc.(LTRPA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 30 percent to $12.05 following TripAdvisor Q1 earnings beat.

    Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 26 percent to $14.48 after the company posted better-than-expected Q1 earnings.

  • [By Lisa Levin]

    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 31 percent to $12.10 following TripAdvisor Q1 earnings beat.

    Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 34 percent to $15.3628 after the company posted better-than-expected Q1 earnings.

  • [By Lisa Levin]

    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares shot up 32 percent to $12.175 following TripAdvisor Q1 earnings beat.

    Shares of ZAGG Inc (NASDAQ: ZAGG) got a boost, shooting up 27 percent to $14.60 after the company posted better-than-expected Q1 earnings.

  • [By Ethan Ryder]

    Engineers Gate Manager LP acquired a new position in Liberty Tripadvisor Holdings Inc Series A (NASDAQ:LTRPA) during the second quarter, Holdings Channel reports. The fund acquired 102,003 shares of the technology company’s stock, valued at approximately $1,642,000.

Top 10 Performing Stocks To Invest In Right Now: China Pharma Holdings Inc.(CPHI)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get Scynexis alerts:

    Steady Activities: SCYNEXIS, Inc. (NASDAQ:SCYX), LPL Financial Holdings Inc. (NASDAQ:LPLA) (oracleexaminer.com) Do Analysts Think You Should Buy – SCYNEXIS Inc (NASDAQ: SCYX) (stockspen.com) Notable Runner: SCYNEXIS, Inc. (SCYX) (nasdaqplace.com) Most Active Stocks Now: SCYNEXIS, Inc. (NASDAQ:SCYX), China Pharma Holdings, Inc. (NYSE:CPHI), Kala … (journalfinance.net) Overview on price to free cash flow: SCYNEXIS, Inc. (NASDAQ:SCYX), InfuSystem Holdings Inc. (NYSE:INFU) (stocksnewspoint.com)

    Several research analysts have recently issued reports on the company. Roth Capital assumed coverage on Scynexis in a research note on Tuesday, May 8th. They set a “buy” rating and a $6.00 price target for the company. Seaport Global Securities assumed coverage on Scynexis in a research note on Tuesday, April 10th. They set a “buy” rating and a $4.00 price target for the company. Zacks Investment Research raised Scynexis from a “hold” rating to a “buy” rating and set a $1.25 price target for the company in a research note on Tuesday, May 8th. HC Wainwright assumed coverage on Scynexis in a research note on Monday, May 7th. They set a “buy” rating and a $5.00 price target for the company. Finally, ValuEngine raised Scynexis from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Scynexis currently has an average rating of “Buy” and an average target price of $4.45.

Top 10 Performing Stocks To Invest In Right Now: Liquidity Services Inc.(LQDT)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Most people who think about retail focus on the hot products that are always in demand. Yet at the other end of the spectrum are the products that perhaps were once needed but now find themselves either out of fashion or no longer necessary for the typical customer. That’s where Liquidity Services (NASDAQ:LQDT) comes in, offering a way for government and private sector clients to dispose of surplus inventory effectively and efficiently. That niche has challenges of its own, but the company has been making moves to build its business back up and hopefully return to profitability.

  • [By Joseph Griffin]

    Eagle Boston Investment Management Inc. grew its stake in Liquidity Services, Inc. (NASDAQ:LQDT) by 4.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 307,736 shares of the business services provider’s stock after purchasing an additional 12,917 shares during the quarter. Eagle Boston Investment Management Inc. owned approximately 0.96% of Liquidity Services worth $2,015,000 as of its most recent SEC filing.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Stephan Byrd]

    Liquidity Services (NASDAQ:LQDT) last issued its quarterly earnings data on Thursday, May 3rd. The business services provider reported ($0.12) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.02. Liquidity Services had a negative net margin of 12.72% and a negative return on equity of 19.31%. The company had revenue of $43.10 million during the quarter, compared to the consensus estimate of $60.16 million. equities analysts forecast that Liquidity Services, Inc. will post -0.71 earnings per share for the current year.

Top 10 Performing Stocks To Invest In Right Now: DBV Technologies S.A.(DBVT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of DBV Technologies (NASDAQ:DBVT) have earned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $44.00.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on DBV Technologies (DBVT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Shares of DBV Technologies (NASDAQ:DBVT) hit a new 52-week low on Tuesday . The stock traded as low as $20.00 and last traded at $20.31, with a volume of 2187 shares trading hands. The stock had previously closed at $20.07.

Top 10 Performing Stocks To Invest In Right Now: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Exelon (EXC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Skba Capital Management LLC reduced its stake in Exelon Co. (NYSE:EXC) by 1.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 199,350 shares of the energy giant’s stock after selling 2,000 shares during the quarter. Skba Capital Management LLC’s holdings in Exelon were worth $8,492,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    US Bancorp DE trimmed its position in shares of Exelon (NYSE:EXC) by 9.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 157,712 shares of the energy giant’s stock after selling 15,626 shares during the quarter. US Bancorp DE’s holdings in Exelon were worth $6,153,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Investors sold shares of Exelon Co. (NYSE:EXC) on strength during trading hours on Thursday. $15.04 million flowed into the stock on the tick-up and $55.72 million flowed out of the stock on the tick-down, for a money net flow of $40.68 million out of the stock. Of all stocks tracked, Exelon had the 21st highest net out-flow for the day. Exelon traded up $0.32 for the day and closed at $44.44

  • [By Garrett Baldwin]

    By following a few simple steps, one IRS directive could help set you up to receive checks of up to $1,795 every single month. Hordes of Americans have already signed their names to the distribution list – and the longer you wait, the greater your risk of missing out on this powerful investment. Click here for more details.

    Three Stocks to Watch Today: FB, AAPL, TSLA
    Shares of Facebook Inc. (NASDAQ: FB) are under pressure after another government took action on the social media giant’s data policies. German regulators announced yesterday that they would limit the company’s ability to collect and combine consumer data and target advertising across all of its services. This ruling could make it far more difficult for the firm if it integrates the messaging platforms of Instagram, Messenger, and WhatsApp. Shares of Apple Inc. (NASDAQ: AAPL) are in focus after news broke that it shifted its modem chip engineering team from its supply chain to its internal hardware group. Reuters suggests that it is aiming to develop modem chips in-house after years of buying them from companies like Qualcomm Inc. (NASDAQ: QCOM) and Intel Corp. (NASDAQ: INTC). Such a change could bolster company profits in a big way in the future. Money Morning Chief Investment Strategist Keith Fitz-Gerald argues that Apple stock is a bargain right now. It’s just one of several that tap into the unstoppable investment trends that can make you very rich. Learn more right here. On Monday (Feb. 4), Tesla Inc. (NASDAQ: TSLA) announced it was acquiring Maxwell Technologies Inc. (NASDAQ: MXWL), a battery and ultra-capacitor company. This might seem like a typical acquisition where a larger company scales its output by buying a smaller competitor. This is a much different move… On Friday, look for earnings reports from Arconic Inc. (NASDAQ: ARNC), Exelon Corp. (NYSE: EXC), Hasbro Inc. (NYSE: HAS), Phillips 66 (NYSE: PSX), and Ventas Inc. (NYSE: VTR).
    Millions of Americans Now Entitled to

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Exelon (EXC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: Moelis & Company(MC)

Advisors’ Opinion:

  • [By Max Byerly]

    Moelis & Co (NYSE:MC) shares traded down 8.7% during mid-day trading on Thursday . The stock traded as low as $60.85 and last traded at $61.10. 920,800 shares changed hands during mid-day trading, an increase of 131% from the average session volume of 398,993 shares. The stock had previously closed at $66.95.

  • [By Logan Wallace]

    Moelis & Co (NYSE:MC) has been given an average recommendation of “Buy” by the seven ratings firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $62.17.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Moelis & Co (MC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: CME Group Inc.(CME)

Advisors’ Opinion:

  • [By Logan Wallace]

    Epoch Investment Partners Inc. grew its holdings in shares of CME Group Inc (NASDAQ:CME) by 51.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,545,562 shares of the financial services provider’s stock after purchasing an additional 528,198 shares during the period. Epoch Investment Partners Inc.’s holdings in CME Group were worth $249,980,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    CME Group Inc (NASDAQ:CME) Director Ronald A. Pankau sold 260 shares of the firm’s stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of $163.17, for a total transaction of $42,424.20. Following the transaction, the director now directly owns 3,900 shares in the company, valued at approximately $636,363. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

  • [By Max Byerly]

    Commonwealth Bank of Australia raised its holdings in CME Group Inc (NASDAQ:CME) by 18.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 26,969 shares of the financial services provider’s stock after purchasing an additional 4,160 shares during the period. Commonwealth Bank of Australia’s holdings in CME Group were worth $4,413,000 at the end of the most recent reporting period.

  • [By Simon Erickson]

    The fourth quarter brought significant market volatility, as investors saw stock prices fall during the final few months of 2018. But CME Group (NASDAQ:CME), the operator of one of America’s largest options and derivatives exchanges, handsomely benefited. Trading volumes related to equity and interest-rate futures tend to spike during volatile times, which is why CME Group enjoyed a boost to its top and bottom lines. 

  • [By Logan Wallace]

    Investors sold shares of CME Group Inc (NASDAQ:CME) on strength during trading hours on Wednesday. $43.03 million flowed into the stock on the tick-up and $84.28 million flowed out of the stock on the tick-down, for a money net flow of $41.25 million out of the stock. Of all stocks tracked, CME Group had the 11th highest net out-flow for the day. CME Group traded up $0.26 for the day and closed at $170.48

Top 10 Performing Stocks To Invest In Right Now: Qorvo, Inc.(QRVO)

Advisors’ Opinion:

  • [By Harsh Chauhan]

    Investors didn’t waste any time expressing their disappointment after Qorvo’s (NASDAQ:QRVO) fourth-quarter 2018 results came out. The chipmaker failed to offer strong guidance for the current quarter, which was enough to blind investors to the fact that it did well to turn its business around to some extent in the previous quarter.

  • [By Joseph Griffin]

    Qorvo Inc (NASDAQ:QRVO) has been given a consensus recommendation of “Hold” by the twenty-seven analysts that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and ten have given a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $83.41.

  • [By Joseph Griffin]

    Qorvo (NASDAQ:QRVO) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Saturday.

  • [By Harsh Chauhan]

    Qorvo (NASDAQ:QRVO) was one of the first Apple suppliers to issue a warning in mid-November, making it clear that weak demand for flagship smartphones will affect its fiscal third-quarter performance. That wasn’t surprising, as Apple supplied more than a third of the chipmaker’s revenue last fiscal year. But there’s a chance of Qorvo surprising investors with a sunny forecast when it releases its official fiscal third-quarter results on Feb. 7. Here’s why.

Hot Clean Energy Stocks To Buy For 2019

Related GOOGL Battery Capacity Over The Years: How Will Goodenough's New Invention Stack Up? Amazon May Be Unable To Achieve The Same Dominance In Cloud It Enjoys In Retail As Easy As ABC – Alphabet Is A Buy! (Seeking Alpha)

Alphabet Inc (NASDAQ: GOOGL)'s Google is betting heavily on sunshine with its Project Sunroof. As environmental issues take the center stage, alternative clean energy sources such as solar energy are gaining traction. And Google isn't one to pass off a promising opportunity.

Having started the project in August 2015, Google sees this avenue as providing it with the leeway to leverage its expansive data in mapping and computing resources to help calculate the best solar plan for consumers. Founded by Google engineer Carl Elkin, the project's stated purpose is "mapping the planet's solar potential, one roof at a time."

Hot Clean Energy Stocks To Buy For 2019: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    News coverage about Caladrius Biosciences (NASDAQ:CLBS) has trended somewhat positive on Friday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Caladrius Biosciences earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 45.4362129030389 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Clean Energy Stocks To Buy For 2019: Aqua America, Inc.(WTR)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Will that be enough to earn its relatively expensive valuation? Perhaps, although analysts aren’t expecting Aqua America to grow nearly as quickly as some of its peers. That’s evidenced by comparing the company to both its larger peer American Water Works and smaller regional peer California Water Services Group.   

    Company Market Cap Dividend Yield Forward P/E Ratio PEG Ratio Enterprise Value-to-EBITDA Ratio
    Aqua America (NYSE:WTR) $6.2 billion 2.4% 23.3 5.05 18
    American Water Works $14.9 billion 2.1% 23.4 3.14 13.2
    California Water Services Group $1.9 billion 1.9% 27 3.02 12.6

    Data source: Yahoo! Finance.

  • [By Motley Fool Transcribers]

    Aqua America Inc (NYSE:WTR)Q2 2018 Earnings Conference CallAug. 2, 2018, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Aqua America (NYSE: WTR) and SJW Group (NYSE:SJW) are both utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Aqua America (NYSE:WTR) from a hold rating to a buy rating in a report released on Friday.

    Several other analysts also recently weighed in on the stock. Zacks Investment Research upgraded shares of Aqua America from a hold rating to a buy rating and set a $41.00 price objective on the stock in a research report on Monday, January 15th. Wells Fargo downgraded shares of Aqua America from an outperform rating to a market perform rating and dropped their price target for the stock from $43.00 to $37.00 in a research report on Monday, February 26th. UBS began coverage on shares of Aqua America in a research report on Thursday, March 8th. They set a neutral rating and a $36.00 price target on the stock. Finally, Boenning Scattergood restated a neutral rating on shares of Aqua America in a research report on Tuesday, April 24th. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of $38.29.

  • [By Shane Hupp]

    Duff & Phelps Investment Management Co. reduced its stake in shares of Aqua America (NYSE:WTR) by 7.1% during the first quarter, Holdings Channel reports. The institutional investor owned 95,640 shares of the utilities provider’s stock after selling 7,290 shares during the quarter. Duff & Phelps Investment Management Co.’s holdings in Aqua America were worth $3,257,000 at the end of the most recent quarter.

  • [By ]

    Aqua America (WTR) : “This is not the stock for a hot economy, even though this is a well-run company.”

    Mueller Water Products (MWA) : “This is not the time to buy. I don’t like the numbers.”

Hot Clean Energy Stocks To Buy For 2019: OpGen, Inc.(OPGN)

Advisors’ Opinion:

  • [By Lisa Levin]

    OpGen, Inc. (NASDAQ: OPGN) shares shot up 15 percent to $2.41. OpGen completed rapid testing clinical trial in Colombia and expanded international operations.

  • [By Lisa Levin]

    OpGen, Inc. (NASDAQ: OPGN) shares shot up 19 percent to $2.50. OpGen completed rapid testing clinical trial in Colombia and expanded international operations.

  • [By Shane Hupp]

    Laboratory Corp. of America (NYSE: LH) and OpGen (NASDAQ:OPGN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

Hot Clean Energy Stocks To Buy For 2019: Inuvo, Inc(INUV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Bard Associates Inc. lifted its stake in Inuvo Inc (NYSEAMERICAN:INUV) by 1,003.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,533,471 shares of the technology company’s stock after acquiring an additional 1,394,471 shares during the period. Bard Associates Inc.’s holdings in Inuvo were worth $1,185,000 as of its most recent filing with the Securities and Exchange Commission.

Hot Clean Energy Stocks To Buy For 2019: Regal Entertainment Group(RGC)

Advisors’ Opinion:

  • [By Peter Graham]

    In December, UK based Cineworld Group Plc also agreed to buy larger U.S. peer Regal Entertainment Group (NYSE: RGC) for $3.6 billion in cash in a deal to create the world’s second largest movie theatre operator after AMC Entertainment Holdings. The combined entity is expected to be better able to compete AMC.

Best Undervalued Stocks To Buy Right Now

Related GWPH Up In Smoke? DoJ Will 'Take Action' Against States That Have Legalized Marijuana Marijuana Stocks Go On Reversal Mode After 8 Weeks Of Gains: Cannabis Index Down From 52-Week High GW Pharma Oncology Is Potential Underrated (Seeking Alpha)
Related ZYNE Up In Smoke? DoJ Will 'Take Action' Against States That Have Legalized Marijuana Benzinga's Top Upgrades, Downgrades For February 24, 2017 Zynerba Pharmaceuticals Undervalued Compared To GW Pharmaceuticals (Seeking Alpha)

Top cannabis stocks took a hit Friday, after White House Press Secretary Sean Spicer suggested the federal government would enforce federal law in states where recreational weed has been legalized, even in spite of the Cole Memo.

Best Undervalued Stocks To Buy Right Now: Churchill Downs, Incorporated(CHDN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Churchill Downs Incorporated (NASDAQ:CHDN)’s share price reached a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $301.60 and last traded at $297.40, with a volume of 6596 shares trading hands. The stock had previously closed at $292.50.

  • [By ]

    Churchill Downs (CHDN) : “This has been a big winner for a long time. I’d wait for a dip, then buy some.”

    Devon Energy (DVN) : “They shot the lights out. They’ve got growth and are bigger than ever.”

  • [By Shane Hupp]

    Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

    Get Churchill Downs alerts:

    Churchill Downs Incorporated (CHDN) Receives Consensus Recommendation of “Buy” from Brokerages (americanbankingnews.com) VIDEO: Churchill CEO Cartstanjen discusses the future of sports betting (bizjournals.com) 2018 Preakness Stakes Preview: Justify Aims For The Triple Crown (finance.yahoo.com) Churchill Downs CEO on future of sports betting (finance.yahoo.com)

    A number of research firms recently weighed in on CHDN. Telsey Advisory Group upped their price target on Churchill Downs from $265.00 to $290.00 and gave the stock a “market perform” rating in a report on Monday, May 7th. ValuEngine raised Churchill Downs from a “hold” rating to a “buy” rating in a report on Friday, April 27th. Zacks Investment Research cut Churchill Downs from a “buy” rating to a “hold” rating in a report on Tuesday, March 20th. Finally, BidaskClub raised Churchill Downs from a “buy” rating to a “strong-buy” rating in a report on Tuesday, April 24th. Three analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. Churchill Downs currently has an average rating of “Buy” and a consensus price target of $260.50.

Best Undervalued Stocks To Buy Right Now: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Undervalued Stocks To Buy Right Now: AMTEK, Inc.(AME)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the news articles that may have impacted Accern Sentiment’s scoring:

    Get AMETEK alerts:

    Ac Power Source Supply Market 2018 Global Share- AMETEK Programmable Power, Pacific Power Source and … (theexpertconsulting.com) The Whispers about AMETEK, Inc. (AME) and Omeros Corporation (OMER) (nmsunews.com) Global Neutron Generators Market Analysis 2018 Del Mar Photonics, VNIIA, AMETEK ORTEC, Adelphi Technology … (theexpertconsulting.com) AMETEK, Inc. (AME): Most Popular stock: (stockquote.review) Ametek granted partial judgment in alleged ground contamination cased filed by mobile home parks’ owners (norcalrecord.com)

    Several research firms have recently commented on AME. Morgan Stanley lifted their price target on shares of AMETEK from $76.00 to $79.00 and gave the company an “equal weight” rating in a research report on Thursday, May 3rd. BMO Capital Markets lifted their price target on shares of AMETEK from $90.00 to $92.00 and gave the company an “outperform” rating in a research report on Thursday, May 3rd. Zacks Investment Research lowered shares of AMETEK from a “buy” rating to a “hold” rating in a research report on Thursday, April 12th. DA Davidson began coverage on shares of AMETEK in a research report on Thursday, April 12th. They set a “buy” rating and a $85.00 price target on the stock. Finally, ValuEngine raised shares of AMETEK from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $82.00.

  • [By Ethan Ryder]

    UBS Group AG boosted its holdings in AMETEK, Inc. (NYSE:AME) by 97.1% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 260,024 shares of the technology company’s stock after acquiring an additional 128,083 shares during the period. UBS Group AG owned about 0.11% of AMETEK worth $19,754,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Douglass Winthrop Advisors LLC purchased a new stake in shares of AMETEK, Inc. (NYSE:AME) during the 1st quarter, Holdings Channel reports. The institutional investor purchased 3,125 shares of the technology company’s stock, valued at approximately $237,000.

  • [By Shane Hupp]

    Mountain Pacific Investment Advisers Inc. ID trimmed its stake in shares of AMETEK, Inc. (NYSE:AME) by 1.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 533,274 shares of the technology company’s stock after selling 5,917 shares during the quarter. AMETEK accounts for 4.2% of Mountain Pacific Investment Advisers Inc. ID’s portfolio, making the stock its 3rd largest holding. Mountain Pacific Investment Advisers Inc. ID’s holdings in AMETEK were worth $40,513,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Legal & General Group Plc lowered its stake in shares of AMETEK, Inc. (NYSE:AME) by 6.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,080,233 shares of the technology company’s stock after selling 73,951 shares during the quarter. Legal & General Group Plc owned about 0.47% of AMETEK worth $82,065,000 at the end of the most recent quarter.

Best Undervalued Stocks To Buy Right Now: Callaway Golf Company(ELY)

Advisors’ Opinion:

  • [By Shane Hupp]

    Callaway Golf (NYSE:ELY) insider Alex Mitchell Boezeman sold 47,012 shares of Callaway Golf stock in a transaction dated Friday, May 4th. The shares were sold at an average price of $17.19, for a total value of $808,136.28. Following the completion of the sale, the insider now owns 107,512 shares of the company’s stock, valued at $1,848,131.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

  • [By Max Byerly]

    Fox Run Management L.L.C. trimmed its holdings in Callaway Golf Co (NYSE:ELY) by 42.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,001 shares of the company’s stock after selling 21,329 shares during the period. Fox Run Management L.L.C.’s holdings in Callaway Golf were worth $550,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Joseph Griffin]

    Granite Springs Asset Management LLC increased its position in shares of Callaway Golf (NYSE:ELY) by 7.4% during the 1st quarter, Holdings Channel reports. The fund owned 72,500 shares of the company’s stock after buying an additional 5,000 shares during the quarter. Granite Springs Asset Management LLC’s holdings in Callaway Golf were worth $1,186,000 at the end of the most recent quarter.

Best Undervalued Stocks To Buy Right Now: Werner Enterprises, Inc.(WERN)

Advisors’ Opinion:

  • [By ]

    Werner Enterprises (Nasdaq: WERN) competes in the full-truckload (FTL) segment of the industry where drivers deliver entire truck-loads between two points, rather than making many stops to consolidate partial loads as in the LTL segment. This could mean that the company has relatively more to gain from autonomous trucking since highway driving is a larger portion of total drive time.

  • [By Max Byerly]

    Werner Enterprises (NASDAQ: WERN) and Universal Logistics (NASDAQ:ULH) are both transportation companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.